Related Experiment Video
Updated: Apr 26, 2026

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
Microvillous atrophy: atypical presentations
Ariane Perry1, Hayet Bensallah, Christine Martinez-Vinson
1*Université Paris-Diderot-Sorbonne Paris Cité, UMR 1149 †Assistance Publique-Hôpitaux de Paris, Hôpital Robert Debré ‡INSERM, UMR1149, Paris §Department of Electron Microscopy, Université François Rabelais, Tours ||Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants-Malades ¶Université Paris Descartes-Sorbonne Paris Cité #Université Paris-Diderot, UMR 698, CHU X. Bichat, Paris, France.
Objectives:
Microvillous inclusion disease (MVID) is a cause of intractable diarrhea in infancy. In its classic form, the disease is characterized by a severe persistent watery diarrhea starting within the first days of life. Parenteral nutrition and small bowel transplantation are the only known treatments for the affected children. Histologically, periodic acid-Schiff (PAS) staining shows accumulation of periodic acid-Schiff-positive staining material along the apical pole of enterocytes, whereas transmission electron microscopy exhibits microvillus inclusion bodies within the cytoplasm of enterocytes with rarefied and shortened microvilli and secretory granules. The objective of this work was to explore clinical, morphological, and genetic findings in cases of MVID with unusual presentations.
Methods:
Clinical, histological, and genetic findings are reported for 8 cases of MVID with atypical presentation.
Results:
The diarrhea started after several months in 3 cases. It was usually less abundant and 3 patients were weaned off parenteral nutrition. None required intestinal transplantation. Three patients experienced malformations, dysmorphy, sensory disabilities, and severe mental retardation. One had a hydrocephaly. Three patients had a cholestasis with low γ-glutamyl transferase levels. Light microscopy showed histological abnormalities consistent with MVID in all of the cases, but the lesions were sometimes focal or delayed. Transmission electron microscopy retrieved some criteria of MVID in 4 patients. Finally, 6 patients were homozygotes or compound heterozygotes for MYO5B mutations.
Conclusions:
This study extends the spectrum of MVID to less severe clinical presentations.
Insights
Microvillous inclusion disease (MVID) can present with less severe symptoms than previously thought. This study found atypical MVID cases with later onset diarrhea and varied clinical outcomes, expanding the disease spectrum.
Area of Science:
- Gastroenterology
- Pediatric Pathology
- Clinical Genetics
Background:
- Microvillous inclusion disease (MVID) typically causes severe, intractable diarrhea in neonates, often requiring parenteral nutrition or intestinal transplantation.
- Classic MVID diagnosis involves characteristic histological findings on PAS staining and electron microscopy of enterocytes.
Observation:
- This study investigated 8 MVID cases with atypical clinical presentations.
- Diarrhea onset was delayed in some cases, with less severity, and some patients were weaned off parenteral nutrition.
- Associated conditions included malformations, dysmorphism, sensory disabilities, and cholestasis.
Findings:
- Histological MVID criteria were present, though sometimes focal or delayed.
- Electron microscopy confirmed MVID features in 4 patients.
- Mutations in the MYO5B gene were identified in 6 out of 8 patients.
Implications:
- The findings broaden the clinical spectrum of MVID to include milder presentations.
- This may lead to earlier diagnosis and potentially different management strategies for some MVID patients.
- Understanding genetic and morphological variations is crucial for comprehensive MVID diagnosis and care.
Related Concept Videos
Inflammatory Bowel Disease IV: Clinical Manifestations
Alzheimer Disease ll: Pathophysiology
Chronic Pancreatitis II: Pathophysiology
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils

